Free Trial

Trinity Biotech (TRIB) SEC Filings & 10K Form

Trinity Biotech logo
$1.32 +0.02 (+1.54%)
(As of 10:17 AM ET)

Recent Trinity Biotech SEC Filings

DateFilerForm TypeView
11/15/2024
4:00 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
11/15/2024
12:22 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
4:26 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
11/07/2024
11:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
12:23 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
12:24 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2024
9:35 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
10:22 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
2:07 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
5:01 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
7:11 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
4:14 PM
Trinity Biotech (Filer)
Form 424B5
09/10/2024
9:35 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
12:26 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
9:52 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
10:59 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
5:01 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
11:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/21/2024
3:40 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
12:52 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
4:26 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
4:27 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
4:03 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
3:53 PM
Trinity Biotech (Filer)
Form 424B5
07/11/2024
5:55 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2024
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
06/28/2024
1:34 PM
Trinity Biotech (Filer)
Form F-3/A
06/21/2024
3:15 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
05/28/2024
6:55 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
12:15 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
05/07/2024
3:25 PM
Trinity Biotech (Filer)
Form 424B3
04/30/2024
4:14 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
04/30/2024
2:48 PM
Trinity Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/30/2024
11:28 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/05/2024
12:05 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
1:11 PM
Trinity Biotech (Filer)
Form 424B3
02/09/2024
6:51 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D
02/01/2024
10:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
10:37 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
3:17 PM
MiCo IVD Holdings, LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
01/02/2024
3:13 PM
MiCo Co., Ltd. (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
01/02/2024
1:02 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2023
12:56 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2023
8:00 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRIB) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners